| Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N Sunaga, T Hisada, ... British journal of cancer 98 (4), 742-748, 2008 | 244 | 2008 |
| Knockdown of oncogenic KRAS in non–small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy N Sunaga, DS Shames, L Girard, M Peyton, JE Larsen, H Imai, J Soh, ... Molecular cancer therapeutics 10 (2), 336-346, 2011 | 192 | 2011 |
| l‐type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N Sunaga, T Hisada, ... Cancer science 99 (12), 2380-2386, 2008 | 180 | 2008 |
| Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer H Imai, K Kaira, N Oriuchi, K Shimizu, H Tominaga, N Yanagitani, ... Anticancer research 30 (12), 4819-4828, 2010 | 154 | 2010 |
| Oncogenic KRAS‐induced interleukin‐8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non‐small cell lung cancer N Sunaga, H Imai, K Shimizu, DS Shames, S Kakegawa, L Girard, M Sato, ... International journal of cancer 130 (8), 1733-1744, 2012 | 128 | 2012 |
| Fluorine-18-α-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study K Kaira, N Oriuchi, Y Otani, K Shimizu, S Tanaka, H Imai, N Yanagitani, ... Clinical Cancer Research 13 (21), 6369-6378, 2007 | 128 | 2007 |
| Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N Sunaga, T Hisada, ... Lung cancer 66 (1), 120-126, 2009 | 119 | 2009 |
| CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N Sunaga, T Hisada, ... Annals of surgical oncology 16, 3473-3481, 2009 | 102 | 2009 |
| Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N Sunaga, T Hisada, ... Pathology-Research and Practice 204 (8), 553-561, 2008 | 81 | 2008 |
| Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer N Sunaga, K Kaira, H Imai, K Shimizu, T Nakano, DS Shames, L Girard, ... Oncogene 32 (34), 4034-4042, 2013 | 78 | 2013 |
| Correlation of angiogenesis with 18F‐FMT and 18F‐FDG uptake in non‐small cell lung cancer K Kaira, N Oriuchi, K Shimizu, T Ishikita, T Higuchi, H Imai, N Yanagitani, ... Cancer science 100 (4), 753-758, 2009 | 74 | 2009 |
| A phase II study of amrubicin, a synthetic 9-aminoanthracycline, in patients with previously treated lung cancer K Kaira, N Sunaga, Y Tomizawa, N Yanagitani, K Shimizu, H Imai, ... Lung Cancer 69 (1), 99-104, 2010 | 70 | 2010 |
| L‐type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non‐small cell lung cancer H Imai, K Kaira, N Oriuchi, N Yanagitani, N Sunaga, T Ishizuka, Y Kanai, ... Histopathology 54 (7), 804-813, 2009 | 70 | 2009 |
| Clinicopathological features of patients with bronchial-associated lymphoid tissue lymphoma H Imai, N Sunaga, K Kaira, O Kawashima, N Yanagitani, K Sato, ... Internal Medicine 48 (5), 301-306, 2009 | 70 | 2009 |
| Effect of platinum-based chemotherapy for non-small cell lung cancer patients with interstitial lung disease H Kenmotsu, T Naito, K Mori, R Ko, A Ono, K Wakuda, H Imai, T Taira, ... Cancer chemotherapy and pharmacology 75, 521-526, 2015 | 69 | 2015 |
| Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non–small-cell lung cancer T Naito, T Okayama, T Aoyama, T Ohashi, Y Masuda, M Kimura, ... BMC cancer 17, 1-9, 2017 | 68 | 2017 |
| Prognostic significance of L‐type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung K Kaira, N Oriuchi, H Imai, K Shimizu, N Yanagitani, N Sunaga, T Hisada, ... Cancer science 100 (2), 249-254, 2009 | 65 | 2009 |
| A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO study protocol S Miura, T Naito, S Mitsunaga, K Omae, K Mori, T Inano, T Yamaguchi, ... BMC cancer 19, 1-10, 2019 | 58 | 2019 |
| Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a … T Naito, T Okayama, T Aoyama, T Ohashi, Y Masuda, M Kimura, ... BMC cancer 17, 1-10, 2017 | 57 | 2017 |
| Clinical significance of post‐progression survival in lung cancer H Imai, K Kaira, K Minato Thoracic Cancer 8 (5), 379-386, 2017 | 56 | 2017 |
